Walgreens has been sued by Arkansas Attorney General Leslie Rutledge, and the case was filed earlier this week. In her filing, she claimed that the pharmacy chain company played a big part in making the opioid crisis situation in the state worse.
Rutledge accused Walgreens of rendering a large number of orders for painkillers, and most of them are suspicious. The lawyer said that this is a violation of Arkansas’ Deceptive Trade Practices Act.
The lawsuit against Walgreens
The lawsuit was filed in Pulaski County Court, and it was stated that the pharmacy did not do enough to make sure that the prescriptions are legitimate and not questionable. It was said that because of Walgreens' failure to monitor the orders, large amounts of the regulated drug were distributed in Arkansas, as per Arkansas Democrat Gazelle.
"Walgreens has a legal responsibility to report suspicious orders and suspicious prescriptions," the attorney general said. "By failing to do so they enabled the black market of prescription drugs to increase dramatically, thus leading to more, greater addiction and more lives lost in the state of Arkansas."
As stated in the lawsuit, from 2006 to 2014, Walgreens fulfilled orders of over 142 million dosages of oxycodone and hydrocodone in the state. Rutledge said that this big amount should have alerted the company to the fact that suspicious orders were being placed.
It was added that such quantities that were distributed in Arkansas far exceeded the normal amount that could be consumed for medical legit purposes. “Walgreens failed to report and halt those orders and instead increased the number of pills distributed,” the statement from the suit reads.
With the filing, the state is seeking a directive that will force Walgreens to act responsibly and comply with federal and state laws. It is also seeking appropriate civil penalties for every violation that the company may have committed against the state’s consumer protection laws.
Walgreens denies the allegations
Walgreens refuted the accusations and stated that it never produced or marketed opioids. The company’s spokesperson further told FOX Business that they never sold the said drug to pain clinics, online pharmacies, and 'pill mills' that worsened the opioid crisis.
"Prior to 2014, we delivered opioids only to our own pharmacies, and the only place we ever sold FDA-approved opioid medications was at the pharmacy counter when presented with valid prescriptions written by DEA-licensed physicians for legitimate medical needs," the firm’s spokesperson said.
Finally, he added that the company’s pharmacists always evaluate and take the law into consideration before deciding whether to fill a prescription for controlled substances.


Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback
Visa to Move European Headquarters to London’s Canary Wharf
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends 



